382 related articles for article (PubMed ID: 28637922)
21. The complement system: a novel therapeutic target for age-related macular degeneration.
Shughoury A; Sevgi DD; Ciulla TA
Expert Opin Pharmacother; 2023; 24(17):1887-1899. PubMed ID: 37691588
[TBL] [Abstract][Full Text] [Related]
22. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
[TBL] [Abstract][Full Text] [Related]
23. Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.
Demirs JT; Yang J; Crowley MA; Twarog M; Delgado O; Qiu Y; Poor S; Rice DS; Dryja TP; Anderson K; Liao SM
Invest Ophthalmol Vis Sci; 2021 Jun; 62(7):26. PubMed ID: 34160562
[TBL] [Abstract][Full Text] [Related]
24. Incidence and progression of geographic atrophy: observations from a population-based cohort.
Joachim N; Mitchell P; Kifley A; Rochtchina E; Hong T; Wang JJ
Ophthalmology; 2013 Oct; 120(10):2042-50. PubMed ID: 23706948
[TBL] [Abstract][Full Text] [Related]
25. Complement inhibition in cynomolgus monkeys by anti-factor d antigen-binding fragment for the treatment of an advanced form of dry age-related macular degeneration.
Loyet KM; Good J; Davancaze T; Sturgeon L; Wang X; Yang J; Le KN; Wong M; Hass PE; van Lookeren Campagne M; Haughney PC; Morimoto A; Damico-Beyer LA; DeForge LE
J Pharmacol Exp Ther; 2014 Dec; 351(3):527-37. PubMed ID: 25232192
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal analysis of reticular drusen associated with geographic atrophy in age-related macular degeneration.
Steinberg JS; Auge J; Jaffe GJ; Fleckenstein M; Holz FG; Schmitz-Valckenberg S;
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4054-60. PubMed ID: 23633663
[TBL] [Abstract][Full Text] [Related]
27. A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease.
Lashkari K; Teague G; Chen H; Lin YQ; Kumar S; McLaughlin MM; López FJ
PLoS One; 2018; 13(5):e0195751. PubMed ID: 29782502
[TBL] [Abstract][Full Text] [Related]
28. Treatment of geographic atrophy: an update on data related to pegcetacoplan.
Patel SB; Heier JS; Chaudhary V; Wykoff CC
Curr Opin Ophthalmol; 2024 Jan; 35(1):64-72. PubMed ID: 37815317
[TBL] [Abstract][Full Text] [Related]
29. Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study.
Jaffe GJ; Schmitz-Valckenberg S; Boyer D; Heier J; Wolf-Schnurrbusch U; Staurenghi G; Schmidt-Erfurth U; Holz FG
Am J Ophthalmol; 2015 Dec; 160(6):1226-34. PubMed ID: 26310670
[TBL] [Abstract][Full Text] [Related]
30. EX-vivo whole blood stimulation with A2E does not elicit an inflammatory cytokine response in patients with age-related macular degeneration.
Durhuus JA; Rozing MP; Nielsen MK; Molbech CR; Keijzers G; Scheibye-Knudsen M; Rasmussen LJ; Westendorp RGJ; Sørensen TL
Sci Rep; 2021 Apr; 11(1):8226. PubMed ID: 33859228
[TBL] [Abstract][Full Text] [Related]
31. Potential role of lampalizumab for treatment of geographic atrophy.
Rhoades W; Dickson D; Do DV
Clin Ophthalmol; 2015; 9():1049-56. PubMed ID: 26089637
[TBL] [Abstract][Full Text] [Related]
32. COMPLEMENT INHIBITION FOR GEOGRAPHIC ATROPHY: Review of Salient Functional Outcomes and Perspective.
Spaide RF; Vavvas DG
Retina; 2023 Jul; 43(7):1064-1069. PubMed ID: 36996460
[TBL] [Abstract][Full Text] [Related]
33. THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.
Boyer DS; Schmidt-Erfurth U; van Lookeren Campagne M; Henry EC; Brittain C
Retina; 2017 May; 37(5):819-835. PubMed ID: 27902638
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM; Patel SS; Staurenghi G; Tadayoni R; Danzig CJ; Eichenbaum DA; Hsu J; Wykoff CC; Heier JS; Lally DR; Monés J; Nielsen JS; Sheth VS; Kaiser PK; Clark J; Zhu L; Patel H; Tang J; Desai D; Jaffe GJ;
Lancet; 2023 Oct; 402(10411):1449-1458. PubMed ID: 37696275
[TBL] [Abstract][Full Text] [Related]
35. Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Keenan TD; Agrón E; Domalpally A; Clemons TE; van Asten F; Wong WT; Danis RG; Sadda S; Rosenfeld PJ; Klein ML; Ratnapriya R; Swaroop A; Ferris FL; Chew EY;
Ophthalmology; 2018 Dec; 125(12):1913-1928. PubMed ID: 30060980
[TBL] [Abstract][Full Text] [Related]
36. Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan.
Steinle NC; Pearce I; Monés J; Metlapally R; Saroj N; Hamdani M; Ribeiro R; Rosenfeld PJ; Lad EM
Am J Ophthalmol; 2021 Jul; 227():116-124. PubMed ID: 33675755
[TBL] [Abstract][Full Text] [Related]
37. [Molecular genetic basis of age-related macular degeneration].
Boĭko ÉV; Churashov SV; Kamilova TA
Vestn Oftalmol; 2013; 129(2):86-90. PubMed ID: 23808188
[TBL] [Abstract][Full Text] [Related]
38. Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration.
Khanani AM; Hershberger VS; Pieramici DJ; Khurana RN; Brunstein F; Ma L; Maass KF; Honigberg LA; Tom I; Chen H; Strauss EC; Lai P;
Am J Ophthalmol; 2021 Dec; 232():49-57. PubMed ID: 34214452
[TBL] [Abstract][Full Text] [Related]
39. Serum lipids in adults with late age-related macular degeneration: a case-control study.
Semba RD; Moaddel R; Cotch MF; Jonasson F; Eiriksdottir G; Harris TB; Launer LJ; Sun K; Klein R; Schaumberg DA; Jónsson P; Gudnason V; Ferrucci L
Lipids Health Dis; 2019 Jan; 18(1):7. PubMed ID: 30621701
[TBL] [Abstract][Full Text] [Related]
40. Lutein and Factor D: two intriguing players in the field of age-related macular degeneration.
Tian Y; Kijlstra A; Webers CAB; Berendschot TTJM
Arch Biochem Biophys; 2015 Apr; 572():49-53. PubMed ID: 25637656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
